The potential relationship between the levels of cancer therapeutic targets in serum, plasma, and tumors might also be of interest because certain targets and/or effectors of oncology drugs were also detected in extracellular fluids as secretory proteins (FDPS, GART, and HMGCS1) [69], in addition to being fitness genes and overexpression in human tumors. This evidence concerns the gene HMGCS1 and cancer.